Misplaced Pages

Conversion disorder (CD), or functional neurologic symptom disorder (FNsD), is a functional disorder that causes abnormal sensory experiences and movement problems during periods of high psychological stress. Individuals with CD present with highly distressing neurological symptoms such as numbness, blindness, paralysis, or convulsions, which are not consistent with a well-established organic cause and can be traced back to a psychological trigger.

It is thought that these symptoms arise in response to stressful situations affecting a patient's mental health or an ongoing mental health condition such as depression. Individuals diagnosed with conversion disorder have a greater chance of experiencing certain psychiatric disorders such as anxiety, depression, and personality disorders compared to those diagnosed with neurological disorders.

Conversion disorder was retained in the DSM-5-TR, but was renamed to functional neurologic symptom disorder (FNsD), a subset of functional neurologic disorder (FND). FND covers the same range of symptoms as FNsD, but does not include the requirements for a psychological stressor to be present. The new criteria no longer requires feigning to be disproven before diagnosing FND nor FNsD. A fifth criterion describing a limitation in sexual functioning that was included in the DSM-4 was removed in the DSM-5 as well. The ICD-11 classifies conversion disorder as a dissociative disorder with unspecified neurological symptoms.

Signs and symptoms

Conversion disorder, originally known as Hysteria and now known as Functional Neurologic Symptom Disorder, presents symptoms following exposure to a certain stressor, typically associated with trauma or psychological distress. Usually, the physical symptoms of the syndrome affect the senses or movement. Common symptoms include blindness, partial or total paralysis, inability to speak, deafness, numbness, difficulty swallowing, incontinence, balance problems, non-epileptic seizures, tremors, and difficulty walking. The symptom of feeling unable to breathe, but where the lips are not turning blue, can indicate conversion disorder or sleep paralysis.

Sleep paralysis and narcolepsy can be ruled out with sleep tests. These symptoms are attributed to conversion disorder when a medical explanation for the conditions cannot be found. Symptoms of conversion disorder usually occur suddenly. Conversion disorder is typically seen in people aged 10 to 35, and affects between 0.011% and 0.5% of the general population.

Conversion disorder can present with motor or sensory symptoms including any of the following:

Motor symptoms or deficits:

• Impaired coordination or balance
• Weakness/paralysis of a limb or the entire body (hysterical paralysis or motor conversion disorders)
• Impairment or loss of speech (hysterical aphonia)
• Difficulty swallowing (dysphagia) or a sensation of a lump in the throat
• Urinary retention
• Psychogenic non-epileptic seizures or convulsions
• Persistent dystonia
• Tremor, myoclonus or other movement disorders
• Gait problems (astasia-abasia)
• Loss of consciousness (fainting)

Sensory symptoms or deficits:

• Impaired vision, double vision
• Impaired hearing
• Loss or disturbance of touch or pain sensation

Conversion symptoms typically do not conform to known anatomical pathways and physiological mechanisms. It has sometimes been stated that the presenting symptoms tend to reflect the patient's own understanding of anatomy and that the less medical knowledge a person has, the more implausible are the presenting symptoms. However, no systematic studies have yet been performed to substantiate this statement. Inconsistent symptoms such as negative lab and imaging results and/or a significant psychiatric disorder are suggestive indicators of functional neurologic disorder. Although the clinician should still exclude any other organic disorders through thorough examination.

Sexual dysfunction and pain are also symptoms of conversion disorder, but if a patient only has these symptoms, they should be diagnosed with sexual pain disorder or pain disorder.

Diagnosis

Definition

Conversion disorder is now contained under the umbrella term functional neurologic symptom disorder (FNsD). In cases of conversion disorder, there is a psychological stressor.

The diagnostic criteria for functional neurologic symptom disorder, as set out in DSM-5, are:

1. The patient has at least one symptom of altered voluntary motor or sensory function.
2. Clinical findings provide evidence of incompatibility between the symptom and recognised neurological or medical conditions.
3. The symptom or deficit is not better explained by another medical or mental disorder.
4. The symptom or deficit causes clinically significant distress or impairment in social, occupational, or other important areas of functioning or warrants medical evaluation.

Specify type of symptom or deficit as:

• With weakness or paralysis
• With abnormal movement (e.g. tremor, dystonic movement, myoclonus, gait disorder)
• With swallowing symptoms
• With speech symptoms (e.g. dysphonia, slurred speech)
• With attacks or seizures
• With amnesia or memory loss
• With special sensory loss symptoms (e.g. visual blindness, olfactory loss, or hearing disturbance)
• With mixed symptoms.

Specify if:

• Acute episode: symptoms present for less than six months
• Persistent: symptoms present for six months or more.

Specify if:

• Psychological stressor (conversion disorder)
• No psychological stressor (functional neurologic symptom disorder)

Exclusion of neurological disease

Conversion disorder presents with symptoms that typically resemble a neurological disorder such as stroke, multiple sclerosis, epilepsy, hypokalemic periodic paralysis, or narcolepsy. The neurologist must carefully exclude neurological disease, through examination and appropriate investigations. However, it is not uncommon for patients with neurological disease to also have conversion disorder.

In excluding neurological disease, the neurologist has traditionally relied partly on the presence of positive signs of conversion disorder, i.e. certain aspects of the presentation that were thought to be rare in neurological disease but common in conversion. The validity of many of these signs has been questioned by a study showing that they also occur in neurological disease. One such symptom, for example, is la belle indifférence, described in DSM-IV as "a relative lack of concern about the nature or implications of the symptoms". In a 2006 study, no evidence was found that patients with functional symptoms are any more likely to exhibit this than patients with a confirmed organic disease. In DSM-V, la belle indifférence was removed as a diagnostic criterion.

Another feature thought to be important was that symptoms tended to be more severe on the non-dominant, usually left side of the body. There have been a number of theories about this, such as the relative involvement of cerebral hemispheres in emotional processing, or more simply, that it was "easier" to live with a functional deficit on the non-dominant side. However, a literature review of 121 studies established that this was not true, with publication bias the most likely explanation for this commonly held view. Although agitation is often assumed to be a positive sign of conversion disorder, release of epinephrine is a well-demonstrated cause of paralysis from hypokalemic periodic paralysis.

Misdiagnosis does sometimes occur. In a highly influential study from the 1960s, Eliot Slater demonstrated that misdiagnoses had occurred in one third of his 112 patients with conversion disorder. Later authors have argued that the paper was flawed. A 2005 meta-analysis has shown that misdiagnosis rates since that paper was published are around four percent, the same as for other neurological diseases.

Psychological mechanism

The psychological mechanism of conversion can be the most difficult aspect of a conversion diagnosis. Even if there is a clear antecedent trauma or other possible psychological trigger, it is still not clear exactly how this gives rise to the symptoms observed. Patients with medically unexplained neurological symptoms may not have any psychological stressor, hence the use of the term "functional neurologic symptom disorder" in DSM-5 as opposed to "conversion disorder", and DSM-5's removal of the need for a psychological trigger. The change of name in the DSM-5 also came with a change of criteria. there was a removal of connection to sexual functioning as well as relation to any other medical condition. There was also an added connection to social and occupational functioning.

Treatment

While conversion symptoms are not a normal responses to stress, taking measures to better manage psychological stress can help relieve symptoms. Treatments for conversion syndrome include hypnosis, psychotherapy, physical therapy, stress management, and transcranial magnetic stimulation. Treatment plans will consider duration and presentation of symptoms and may include one or multiple of the above treatments. This may include the following:

1. Occupational therapy to maintain autonomy in activities of daily living.
2. Treatment of comorbid depression or anxiety if present..
3. Educating patients on the causes of their symptoms might help them learn to manage both the psychiatric and physical aspects of their condition. Psychological counseling is often warranted given the known relationship between conversion disorder and emotional trauma. This approach ideally takes place alongside other types of treatment.
4. Medications such as serotonin–norepinephrine reuptake inhibitors (SNRIs), a class of antidepressants, and sedatives such as benzodiazepines may help reduce stress and also relieve or prevent symptoms from occurring.

There is little evidence-based treatment of conversion disorder. Other treatments such as cognitive behavioral therapy, hypnosis, EMDR, and psychodynamic psychotherapy, EEG brain biofeedback need further trials. Psychoanalytic treatment may possibly be helpful. Most studies assessing the efficacy of these treatments are of poor quality and larger, better controlled studies are urgently needed. Cognitive behavioral therapy (CBT) is the most common treatment, with a 13% improvement rate.

Prognosis

Empirical studies have found that the prognosis for conversion disorder varies widely, with some cases resolving in weeks, and others enduring for years or decades. There is also evidence that there is no cure for conversion disorder, and that although patients may go into remission they can relapse at any point. Many patients can get rid of their symptoms with time, treatments and reassurance.

Epidemiology

Frequency

Information on the frequency of conversion disorder in the West is limited, in part due to the complexities of the diagnostic process. In neurology clinics, the reported prevalence of unexplained symptoms among new patients is very high, between 30 and 60%. However, diagnosis of conversion disorder typically requires an additional psychiatric evaluation, and since few patients will see a psychiatrist, it is unclear what proportion of the unexplained symptoms are actually due to the disorder. In 1976, large scale psychiatric registers in the U.S. and Iceland found incidence rates of 22 and 11 newly diagnosed cases per 100,000 person-years, respectively. In 2002, some estimates claim that in the general population, between 0.011% and 0.5% of the population have conversion disorder.

Culture

Although it is often thought that the frequency of conversion may be higher outside of the West, perhaps in relation to cultural and medical attitudes, evidence of this is limited. A 2007 community survey of urban Turkey found a prevalence of 5.6%. Many authors have found occurrence of conversion to be more frequent in rural, lower socio-economic groups, where technological investigation of patients is limited and people may know less about medical and psychological concepts.

Gender

In recent surveys of conversion disorder, females predominate, with between two and six female patients for every male. Some research suggests however that this gender disparity may be confounded by higher rates of violence against women.

Age

Conversion disorder may present at any age, but is rare in children younger than ten or in the elderly. Studies suggest a peak onset in the mid-to-late 30s.

History

The first evidence of conversion disorder dates back to 1900 B.C., when the symptoms were blamed on the uterus moving within the female body. The treatment varied "depending on the position of the uterus, which must be forced to return to its natural position. If the uterus had moved upwards, this could be done by placing malodorous and acrid substances near the woman's mouth and nostrils, while scented ones were placed near her vagina; on the contrary, if the uterus had lowered, the document recommends placing the acrid substances near her vagina and the perfumed ones near her mouth and nostrils."

In Greek mythology, hysteria, a similarly described condition, was thought to be caused by a lack of orgasms, uterine melancholy, and not procreating. Plato, Aristotle, and Hippocrates believed that a lack of sex causes complications in the uterus. Many Greeks believed it could be prevented and cured with wine and orgies. Hippocrates argued that a lack of regular sexual intercourse led to the uterus producing toxic fumes, causing it to move in the body. Therefore, he argued, all women should be married and enjoy a satisfactory sexual life.

Donald Capps argues that the diseases Jesus allegedly healed, such as paralysis and blindness, were actually forms of conversion disorder. He describes Jesus as a "village psychiatrist", who believed that his words had power.

From the 13th century, women with hysteria were exorcised, as it was believed that they were possessed by the devil. It was believed that if doctors could not find the cause of a disease or illness, it must be caused by the devil.

At the beginning of the 16th century, women were sexually stimulated by midwives in order to relieve their symptoms. Gerolamo Cardano and Giambattista della Porta believed polluted water and fumes caused the symptoms of hysteria. Towards the end of the century, the role of the uterus was no longer thought central to the disorder, with Thomas Willis discovering that the brain and central nervous system were the cause of the symptoms. Thomas Sydenham argued that the symptoms of hysteria may have an organic cause. He also proved the uterus is not the cause of symptoms.

In 1692, in the U.S. town of Salem, Massachusetts, there was a reported outbreak of hysteria. This led to the Salem witch trials, where women who were accused of being witches had symptoms such as sudden movements, staring eyes, and uncontrollable jumping.

During the 18th century, there was a move from the idea of hysteria being caused by the uterus to it being caused by the brain. This led to an understanding that it could affect both sexes. Jean-Martin Charcot argued that hysteria was caused by "a hereditary degeneration of the nervous system, namely a neurological disorder".

In the 19th century, hysteria moved from being considered a neurological disorder to being considered a psychological disorder, when Pierre Janet argued that "dissociation appears autonomously for neurotic reasons, and in such a way as to adversely disturb the individual's everyday life". As early as 1874, doctors including W. B. Carpenter and J. A. Omerod began to speak out against the hysteria phenomenon as there was no evidence to prove its existence.

Sigmund Freud referred to the condition as both hysteria and conversion disorder throughout his career. He believed those with the condition could not live in a mature relationship, and that those with the condition were unwell in order to achieve a "secondary gain", in that they are able to manipulate their situation to fit their needs or desires. He also found that both men and women could have the disorder.

Freud's model suggested the emotional charge deriving from painful experiences would be consciously repressed as a way of managing the pain, but that the emotional charge would be somehow "converted" into neurological symptoms. Freud later argued that the repressed experiences were of a sexual nature. As Peter Halligan comments, conversion has "the doubtful distinction among psychiatric diagnoses of still invoking Freudian mechanisms".

Pierre Janet, a highly noted psychologist during the early 20th century, argued that symptoms arose through the power of suggestion, acting on a personality vulnerable to dissociation. In this hypothetical process, the subject's experience of their leg, for example, is split off from the rest of their consciousness, resulting in paralysis or numbness in that leg.

Some support for the Freudian model comes from findings of high rates of childhood sexual abuse in conversion patients. Support for the dissociation model comes from studies showing heightened suggestibility in patients with conversion disorder. Critics argue that it can be challenging to find organic pathologies for all symptoms, and so the practice of diagnosing patients with such symptoms as having hysteria led to the disorder being meaningless, vague and a sham diagnosis, as it does not refer to any definable disease.

Throughout its history, many patients have been misdiagnosed with hysteria or conversion disorder when they had organic disorders such as tumors, epilepsy, or vascular diseases. This has led to patient deaths, a lack of appropriate care, and suffering for the patients.

Eliot Slater, after studying the condition in the 1950s, stated: "The diagnosis of 'hysteria' is all too often a way of avoiding a confrontation with our own ignorance. This is especially dangerous when there is an underlying organic pathology, not yet recognised. In this penumbra we find patients who know themselves to be ill but, coming up against the blank faces of doctors who refuse to believe in the reality of their illness, proceed by way of emotional lability, overstatement and demands for attention ... Here is an area where catastrophic errors can be made. In fact it is often possible to recognise the presence though not the nature of the unrecognisable, to know that a man must be ill or in pain when all the tests are negative. But it is only possible to those who come to their task in a spirit of humility. In the main the diagnosis of 'hysteria' applies to a disorder of the doctor–patient relationship. It is evidence of non-communication, of a mutual misunderstanding ... We are, often, unwilling to tell the full truth or to admit to ignorance ... Evasions, even untruths, on the doctor's side are among the most powerful and frequently used methods he has for bringing about an efflorescence of 'hysteria'".

The onset of conversion disorder often correlates to a traumatic or stressful event. There are certain populations that are considered at risk for conversion disorder, including people with a medical illness or condition, people with personality disorders or dissociative disorders. No biomarkers have yet been found to support the idea that conversion disorder is caused by a psychiatric condition.

There has been much recent interest in using functional neuroimaging to study conversion. As researchers identify the mechanisms which underlie conversion symptoms, it is hoped they will enable the development of a neuropsychological model. A number of such studies have been performed, including some which suggest the blood-flow in patients' brains may be abnormal while they are unwell. The studies have all been too small to be confident of the generalisability of their findings, so no neuropsychological model has been clearly established.

An evolutionary psychology explanation for conversion disorder is that the symptoms may have been evolutionarily advantageous during warfare. A non-combatant with these symptoms signals non-verbally, possibly to someone speaking a different language, that she or he is not dangerous as a combatant and also may be carrying some form of dangerous infectious disease. This can explain that conversion disorder may develop following a threatening situation, that there may be a group effect with many people simultaneously developing similar symptoms, as in mass psychogenic illness, and the gender difference in prevalence.

See also

• Body-centred countertransference
• Functional neurologic disorder (FND)
• Post-traumatic stress disorder (PTSD) and Complex post-traumatic stress disorder (C-PTSD)
• Somatic symptom disorder
• Functional disorder

References

1. Peeling, Jessica L.; Muzio, Maria Rosaria (2024), "Functional Neurologic Disorder", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 31855394, retrieved June 30, 2024
2. Peeling, Jessica L.; Muzio, Maria Rosaria (2024), "Functional Neurologic Disorder", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 31855394, retrieved June 30, 2024
3. Kanaan, R.A.A. (2022).
4. World Health Organization (2023). "6B60 Dissociative neurological with unspecified symptoms ". International Classification of Diseases, eleventh revision – ICD-11. Genova – icd.who.int.
5. World Health Organization (2023). "6B60.Z Dissociative neurological symptom disorder, with unspecified symptoms ". International Classification of Diseases, eleventh revision – ICD-11. Genova – icd.who.int.
6. Kanaan, R.A.A. (2022).
7. ^ "Conversion disorder". National Center for Biotechnology Information, U.S. National Library of Medicine. November 17, 2012. Retrieved October 25, 2013.
8. ^ Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, American Psychiatric Association
9. ^ Tollison, C. David; Satterthwaite, John R.; Tollison, Joseph W. (January 1, 2002). Practical Pain Management. Lippincott Williams & Wilkins. ISBN 9780781731607.
10. Peeling, Jessica L.; Muzio, Maria Rosaria (2023), "Conversion Disorder", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 31855394, retrieved May 5, 2023
11. Peeling, Jessica L.; Muzio, Maria Rosaria (2024), "Functional Neurologic Disorder", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 31855394, retrieved June 30, 2024
12. Stern, Theodore A.; Fricchione, Gregory L.; Rosenbaum, Jerrold F. (2010). Massachusetts General Hospital Handbook of General Hospital Psychiatry (6th ed.). Elsevier. pp. 211–236. ISBN 9781437719277.
13. "Conversion and somatic symptom disorders". Retrieved November 25, 2015.
14. ^ Stone J, Carson A, Sharpe M (2005). "Functional symptoms and signs in neurology: assessment and diagnosis". J. Neurol. Neurosurg. Psychiatry. 76 (Suppl 1): i2–12. doi:10.1136/jnnp.2004.061655. PMC 1765681. PMID 15718217.
15. Eames P (1992). "Hysteria following brain injury". J. Neurol. Neurosurg. Psychiatry. 55 (11): 1046–53. doi:10.1136/jnnp.55.11.1046. PMC 1015291. PMID 1469401.
16. Gould R, Miller BL, Goldberg MA, Benson DF (1986). "The validity of hysterical signs and symptoms". J. Nerv. Ment. Dis. 174 (10): 593–7. doi:10.1097/00005053-198610000-00003. PMID 3760849. S2CID 38888726.
17. Stone J, Smyth R, Carson A, Warlow C, Sharpe M (2006). "La belle indifférence in conversion symptoms and hysteria: systematic review". Br J Psychiatry. 188: 204–9. doi:10.1192/bjp.188.3.204. PMID 16507959.
18. Stone J, Sharpe M, Carson A, Lewis SC, Thomas B, Goldbeck R, Warlow CP (2002). "Are functional motor and sensory symptoms really more frequent on the left? A systematic review". J. Neurol. Neurosurg. Psychiatry. 73 (5): 578–81. doi:10.1136/jnnp.73.5.578. PMC 1738113. PMID 12397155.
19. "Segal MM, Jurkat-Rott K, Levitt J, Lehmann-Horn F, Hypokalemic periodic paralysis—an owner's manual". Uni-ulm.de. June 5, 2009. Retrieved November 30, 2013.
20. Slater E (1965). "Diagnosis of Hysteria". Br Med J. 1 (5447): 1395–9. doi:10.1136/bmj.1.5447.1395. PMC 2166300. PMID 14286998.
21. Slater ET, Glithero E (1965). "A follow-up of patients diagnosed as suffering from "hysteria"". J Psychosom Res. 9 (1): 9–13. doi:10.1016/0022-3999(65)90004-8. PMID 5857619.
22. Stone J, Warlow C, Carson A, Sharpe M (2005). "Eliot Slater's myth of the non-existence of hysteria". J R Soc Med. 98 (12): 547–8. doi:10.1177/014107680509801214. PMC 1299341. PMID 16319432.
23. Ron M, "The Prognosis of Hysteria" In P. Halligan, C. Bass, J. Marshall (Eds.) Hysterical Conversion: clinical and theoretical perspectives (pp. 73–87). Oxford: Oxford University Press.
24. Kanaan, R.A.A. (2022).
25. "Conversion disorder". Mayo Foundation for Medical Education and Research. Retrieved October 25, 2013.
26. Stone J, Carson A, Sharpe M (2005). "Functional symptoms in neurology: management". J. Neurol. Neurosurg. Psychiatry. 76 (Suppl 1): i13–21. doi:10.1136/jnnp.2004.061663. PMC 1765682. PMID 15718216.
27. "Conversion Disorder | Doctors of USC". www.doctorsofusc.com. Archived from the original on August 22, 2008. Retrieved January 13, 2022.
28. Ganslev, Christina A.; Storebø, Ole Jakob; Callesen, Henriette E.; Ruddy, Rachel; Søgaard, Ulf (July 17, 2020). "Psychosocial interventions for conversion and dissociative disorders in adults". The Cochrane Database of Systematic Reviews. 2020 (7): CD005331. doi:10.1002/14651858.CD005331.pub3. ISSN 1469-493X. PMC 7388313. PMID 32681745.
29. Feinstein A (2011). "Conversion disorder: advances in our understanding". CMAJ. 183 (8): 915–20. doi:10.1503/cmaj.110490. PMC 3091899. PMID 21502352.
30. Mace, CJ; Trimble, MR (September 1996). "Ten-year prognosis of conversion disorder". The British Journal of Psychiatry. 169 (3): 282–8. doi:10.1192/bjp.169.3.282. PMID 8879713. S2CID 7549659.
31. Couprie, W; Wijdicks, EF; Rooijmans, HG; van Gijn, J (June 1995). "Outcome in conversion disorder: a follow up study". Journal of Neurology, Neurosurgery, and Psychiatry. 58 (6): 750–2. doi:10.1136/jnnp.58.6.750. PMC 1073562. PMID 7608683.
32. ^ Carson AJ, Ringbauer B, Stone J, McKenzie L, Warlow C, Sharpe M (2000). "Do medically unexplained symptoms matter? A prospective cohort study of 300 new referrals to neurology outpatient clinics". J. Neurol. Neurosurg. Psychiatry. 68 (2): 207–10. doi:10.1136/jnnp.68.2.207. PMC 1736779. PMID 10644789.
33. Nimnuan C, Hotopf M, Wessely S (2001). "Medically unexplained symptoms: an epidemiological study in seven specialities". J Psychosom Res. 51 (1): 361–7. doi:10.1016/s0022-3999(01)00223-9. PMID 11448704.
34. Snijders TJ, de Leeuw FE, Klumpers UM, Kappelle LJ, van Gijn J (2004). "Prevalence and predictors of unexplained neurological symptoms in an academic neurology outpatient clinic—an observational study". J. Neurol. 251 (1): 66–71. doi:10.1007/s00415-004-0273-y. PMID 14999491. S2CID 8191138.
35. Crimlisk HL, Bhatia KP, Cope H, David AS, Marsden D, Ron MA (2000). "Patterns of referral in patients with medically unexplained motor symptoms". J Psychosom Res. 49 (3): 217–9. doi:10.1016/s0022-3999(00)00167-7. PMID 11110993.
36. ^ Stefánsson JG, Messina JA, Meyerowitz S (1976). "Hysterical neurosis, conversion type: clinical and epidemiological considerations". Acta Psychiatr Scand. 53 (2): 119–38. doi:10.1111/j.1600-0447.1976.tb00066.x. PMID 1251758. S2CID 39279206.
37. Akagi, H. & House, A.O., 2001, "The epidemiology of hysterical conversion". In P. Halligan, C. Bass, J. Marshall (Eds.) Hysterical Conversion: clinical and theoretical perspectives (pp. 73–87). Oxford: Oxford University Press.
38. ^ Deveci A, Taskin O, Dinc G, Yilmaz H, Demet MM, Erbay-Dundar P, Kaya E, Ozmen E (2007). "Prevalence of pseudoneurologic conversion disorder in an urban community in Manisa, Turkey". Soc Psychiatry Psychiatr Epidemiol. 42 (11): 857–64. doi:10.1007/s00127-007-0233-9. PMID 17639308. S2CID 35026784.
39. Tomasson K, Kent D, Coryell W (1991). "Somatization and conversion disorders: comorbidity and demographics at presentation". Acta Psychiatr Scand. 84 (3): 288–93. doi:10.1111/j.1600-0447.1991.tb03146.x. PMID 1950631. S2CID 7567719.
40. Kuloglu M, Atmaca M, Tezcan E, Gecici O, Bulut S (2003). "Sociodemographic and clinical characteristics of patients with conversion disorder in Eastern Turkey". Soc Psychiatry Psychiatr Epidemiol. 38 (2): 88–93. doi:10.1007/s00127-003-0608-5. PMID 12563551. S2CID 21829547.
41. Kletenik, I; Sillau, SH; Attaripour Isfahani, S; LaFaver, K; Hallett, M; Berman, BD (November 29, 2019). "Gender as a Risk Factor for Functional Movement Disorders: The Role of Sexual Abuse". Movement Disorders Clinical Practice. 7 (2): 177–181. doi:10.1002/mdc3.12863. PMC 7011626. PMID 32071936.
42. Kletenik I, Holden SK, Sillau SH, O'Connell N, MacGillivray L, Mack J, Haddock B, Ashworth Dirac M, David AS, Nicholson TR, Attaripour Isfahani SN, Maurer CW, Lidstone SC, Hallett M, LaFaver K, Berman BD, Stone J (January 2022). "Gender disparity and abuse in functional movement disorders: a multi-center case-control study". J Neurol. 269 (6): 3258–3263. doi:10.1007/s00415-021-10943-6. PMC 10202134. PMID 35098346. S2CID 246413303.
43. ^ Tasca, Cecilia; Rapetti, Mariangela; Carta, Mauro Giovanni; Fadda, Bianca (October 19, 2012). "Women And Hysteria In The History Of Mental Health". Clinical Practice and Epidemiology in Mental Health. 8: 110–119. doi:10.2174/1745017901208010110. ISSN 1745-0179. PMC 3480686. PMID 23115576.
44. Capps, Donald (2010). "Jesus the village psychiatrist: a summary". HTS Theological Studies. 66 (1) – via Scielo.
45. Webster, Richard. "The hysteria diagnosis: Freud, Charcot, Breuer and Anna O". www.richardwebster.net. Archived from the original on May 11, 2004. Retrieved February 29, 2016.{{cite web}}: CS1 maint: unfit URL (link)
46. Josef Breuer & Sigmund Freud, Studies in Hysteria, 1895
47. Freud S (1905). Fragment of an analysis of a case of hysteria.
48. Halligan PW, Bass C, Wade DT (2000). "New approaches to conversion hysteria". BMJ. 320 (7248): 1488–9. doi:10.1136/bmj.320.7248.1488. PMC 1118088. PMID 10834873.
49. Janet P (1920). The Major Symptoms of Hysteria (2nd ed.).
50. Roelofs K, Keijsers GP, Hoogduin KA, Näring GW, Moene FC (2002). "Childhood abuse in patients with conversion disorder" (PDF). Am J Psychiatry. 159 (11): 1908–13. doi:10.1176/appi.ajp.159.11.1908. hdl:1887/14240. PMID 12411227. S2CID 24809182.
51. Roelofs K, Hoogduin KA, Keijsers GP, Näring GW, Moene FC, Sandijck P (2002). "Hypnotic susceptibility in patients with conversion disorder" (PDF). J Abnorm Psychol. 111 (2): 390–5. doi:10.1037/0021-843x.111.2.390. hdl:1887/14289. PMID 12003460. S2CID 31958662.
52. ^ Webster, Richard. "Sigmund Freud: hysteria, somatization, medicine and misdiagnosis". www.richardwebster.net. Archived from the original on May 11, 2004. Retrieved February 21, 2016.{{cite web}}: CS1 maint: unfit URL (link)
53. Bracha HS (2006). "Human brain evolution and the "Neuroevolutionary Time-depth Principle:" Implications for the Reclassification of fear-circuitry-related traits in DSM-V and for studying resilience to warzone-related posttraumatic stress disorder" (PDF). Progress in Neuro-Psychopharmacology and Biological Psychiatry. 30 (5): 827–853. doi:10.1016/j.pnpbp.2006.01.008. PMC 7130737. PMID 16563589.

External links

• Disorders causing seizures
• Mass psychogenic illness
• Somatic symptom disorders